Form 4: Medpace CFO Sells Shares After Option Exercise

Sentiment:

Insider Transaction Report


Medpace Holdings, Inc. CFO Kevin M. Brady exercised stock options and subsequently sold a portion of the acquired shares, while also gifting a small number of shares.

Summary

  • CFO Kevin M. Brady exercised employee stock options to acquire 3,000 shares of Medpace Holdings, Inc. common stock at an exercise price of $166.73 per share.
  • Concurrently, Brady sold 3,000 shares of common stock at a weighted average price of $590.35 per share, with individual transactions ranging from $590.00 to $590.72.
  • Brady also gifted 170 shares of common stock to a donor-advised fund.
  • Following these transactions, Brady directly beneficially owns 5,830 shares of Medpace Holdings, Inc. common stock.
  • The options exercised had vested in full on October 27, 2025.

Sentiment

Score: 6

Explanation: The filing reports routine insider transactions (option exercise and sale) by a CFO. While the sale reduces direct shareholding, it's a common practice to monetize vested equity compensation, especially given the significant gain from the exercise price to the sale price. The gift is a personal philanthropic act. Overall, it's a neutral to slightly positive signal due to the executive realizing substantial value, but not a strong indicator of future company performance.

Positives

  • The exercise of options and subsequent sale indicates the executive is realizing value from previously granted equity compensation.
  • The sale price of $590.35 per share is significantly higher than the exercise price of $166.73, demonstrating substantial appreciation in the company's stock value.

Negatives

  • The sale of 3,000 shares by a key executive (CFO) could be interpreted by some investors as a reduction in direct exposure to the company's future performance, although it is a common practice for option exercises.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: May view the sale as a routine monetization of equity compensation, or potentially as a slight reduction in insider alignment, depending on their interpretation. The significant gain realized by the CFO could be seen positively, reflecting stock appreciation.

Key Dates

DateDescription
10/27/2025Date when the employee stock option vested in full.
11/21/2025Date of the reported transactions, including option exercise, share sale, and share gift.
11/25/2025Signature date of the reporting person's attorney-in-fact.
10/27/2026Expiration date of the employee stock option.

Recommendation

hold

This Form 4 filing details a routine insider transaction where the CFO exercised vested stock options and subsequently sold an equivalent number of shares, realizing a substantial gain. While the sale reduces the executive's direct shareholding, it is a common practice for monetizing equity compensation and does not inherently signal a change in the company's fundamental outlook. The transaction does not provide new information to warrant a change in investment thesis, thus a 'hold' recommendation is appropriate for existing investors.

Keywords

Medpace Holdings, MEDP, Insider Trading, Form 4, Stock Option Exercise, Share Sale, CFO, Kevin M. Brady, Equity Compensation, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.